BPC-157 + TB-500 Combination BPC-157 10mg + TB-500 10mg — Research-Grade Pre-Formulated Healing Peptide Blend

Document ID: HKPW-bpc-157-tb-500-10-mg-research-peptide-co-v1.0 | Reviewed by: HKPEPTIDE WORLDWIDE Research Team | Last Updated: 2026-08-08

Product Identity & Specifications

Parameter	Specification
Product Name	BPC-157 + TB-500 Combination
Dosage	BPC-157 10mg + TB-500 10mg
CAS Number	N/A (blend)
Molecular Formula	C₆₂H₉₈N₁₆O₂₂ / C₃₈H₆₈N₁₀O₁₄
Molecular Weight	~1419.5 / ~889 Da
Sequence	BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Purity	≥99% HPLC
Appearance	White to off-white lyophilized powder
Solubility	Soluble in sterile water or bacteriostatic water
Storage	2–8°C, desiccated, protected from light
Classification	Pre-Formulated Healing Peptide Blend

Research Background

The BPC-157 + TB-500 combination is a pre-formulated research peptide blend that pairs two mechanistically complementary healing peptides in a single kit. This is our most frequently ordered combination product, reflecting the well-documented synergy between BPC-157’s angiogenic and cytoprotective signaling and TB-500’s actin-mediated cell migration. Rather than ordering two separate products and managing two COAs, researchers receive a single batch-documented kit with unified quality documentation — simplifying inventory, reducing weighing errors, and ensuring consistent batch-to-batch ratios. Each peptide component is individually verified by HPLC and MS before combination.

The BPC-157 10mg + TB-500 10mg configuration is manufactured under strict quality control protocols. Each batch undergoes HPLC purity verification, ESI-MS identity confirmation, and amino acid analysis. A batch-specific Certificate of Analysis (COA) is included with every order. Bulk and OEM configurations available for qualifying wholesale accounts.

Molecular Mechanisms

BPC-157: VEGF-Driven Angiogenesis

Upregulates VEGF at injury sites → new capillary formation → enhanced tissue perfusion. Creates the vascular infrastructure for tissue repair.

TB-500: Actin-Mediated Cell Migration

G-actin sequestration → maintains polymerization-ready actin pool → lamellipodia/filopodia formation → directional cell migration into wound beds. Mobilizes the cellular repair machinery.

Synergistic Pathway Integration

BPC-157’s NO-mediated vasodilation enhances delivery of TB-500-mobilized repair cells to injury sites. Simultaneous VEGF upregulation + actin dynamics activation produces greater net tissue repair than either peptide alone in preclinical wound models.

Research Applications

Soft Tissue Injury Repair
Surgical Recovery Models
Tendon & Ligament Healing
Wound Healing & Angiogenesis
Combination Regenerative Research

Comparative Analysis

Compared to single-agent BPC-157 or TB-500: The combination addresses both the angiogenic signal (BPC-157) and cellular migration machinery (TB-500) simultaneously. Single-agent protocols require separate sourcing, reconstitution, and QC verification of two products. The pre-formulated blend provides both mechanisms in one kit with unified documentation.

Quality Control & Analytical Specifications

Parameter	Method	Specification
Purity	HPLC at 214 nm, C18 column	≥99.0% peak area
Identity (MW)	ESI-MS	~1419.5 / ~889 Da
Appearance	Visual inspection	White to off-white powder
Peptide Content	Amino acid analysis	≥80% net peptide
Residual Moisture	Karl Fischer titration	≤3%
Endotoxin	LAL assay	≤0.5 EU/mg

Available Configurations

Configuration	Content	Best For
Standard Kit	BPC-157 10mg + TB-500 10mg × 10 vials	Evaluation; protocol validation
Bulk Kit	Custom × 10 vials	Chronic studies; repeat orders
OEM/Private Label	Custom	Branded product development

Frequently Asked Questions

Q: Why are BPC-157 and TB-500 combined?

BPC-157 creates new blood vessels (angiogenesis). TB-500 moves repair cells into position (cell migration). Together: vessels are built AND cells are mobilized — synergistic tissue repair. This complementary mechanism pairing is the most studied peptide combination in preclinical healing research.

Q: Are the peptides co-lyophilized or separate vials?

Separate vials in one kit — each peptide is lyophilized individually under optimized conditions. This preserves the stability profile of each peptide while providing unified batch documentation (single COA, single kit number).

Q: What documentation is provided?

Single COA covering both peptides: individual HPLC purities (≥99% each), individual ESI-MS identities, combined kit batch number. Full analytical data package on request.

Q: Can I get custom BPC/TB ratios?

Yes. Standard is 1:1 (e.g., 10mg+10mg). Custom ratios (e.g., 10mg BPC + 5mg TB) available for qualifying bulk orders. Contact our team for custom blend development.

Tiered Wholesale Pricing

Volume	Discount	For
1 kit	List price	Evaluation; competitive analysis
5+ kits	10% off	Initial portfolio expansion
20+ kits	20% off	Mid-size distributors
50+ kits	30% off	Regional distributors

Contact our team for 100+ kit custom pricing. Mixed-molecule orders qualify for combined volume tiers.

Resource	Description
Healing Regenerative Peptides Hub	Complete research overview & methodology hub
Bpc 157 5 Mg Body Protection Research Pe	Related research peptide product
Bpc 157 Tb 500 10 Mg Research Peptide Co	Related research peptide product
Why Anti Aging Peptide Research Is Growing Rapidly	Latest research insights & methodology

View Complete Research Guide »

Compliance Statement

FOR LABORATORY RESEARCH USE ONLY. Not for human or veterinary diagnostic, therapeutic, or prophylactic use. Not a dietary supplement, pharmaceutical ingredient, or approved drug. Researchers must comply with all applicable institutional, local, and national regulations.

BPC-157/TB-500 Blend 10 mg